Search research articles
Contact Us
Filters
Showing results (51-60 of 132) with videos related to
Page
of 14
Sort By:
Cancers
|
March 7, 2020
Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile
Jean Camille Mattei, Corinne Bouvier-Labit, Doriane Barets, et al.
Virchows Archiv : an International Journal of Pathology
|
December 16, 2015
Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions
Jérôme Doyen, Valérie Duranton-Tanneur, Isabelle Hostein, et al.
Clinical Sarcoma Research
|
September 7, 2012
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients
Florence Duffaud, Caroline Even, Isabelle Ray-Coquard, et al.
Journal of Palliative Medicine
|
February 17, 2012
Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care
Sébastien Salas, Matthieu Frasca, Brigitte Planchet-Barraud, et al.
Targeted Oncology
|
June 5, 2021
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study
Almudena Callejo, Sara Faouzi, Olivier Bouché, et al.
Anti-Cancer Drugs
|
May 31, 2008
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy
Charlotte Dupuis, Cedric Mercier, Chenguang Yang, et al.
Nature Communications
|
January 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial
Robin L Jones, Roman Groisberg, Jean-Yves Blay, et al.
Scientific Reports
|
June 5, 2017
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
François Becher, Joseph Ciccolini, Diane-Charlotte Imbs, et al.
Therapeutic Drug Monitoring
|
October 14, 2006
A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy
Joseph Ciccolini, Cédric Mercier, Alexandre Evrard, et al.
The Oncologist
|
August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 132) with videos related to
Sort By:
Page
of 14
Cancers
|
March 7, 2020
Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile
Jean Camille Mattei, Corinne Bouvier-Labit, Doriane Barets, et al.
Virchows Archiv : an International Journal of Pathology
|
December 16, 2015
Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions
Jérôme Doyen, Valérie Duranton-Tanneur, Isabelle Hostein, et al.
Clinical Sarcoma Research
|
September 7, 2012
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients
Florence Duffaud, Caroline Even, Isabelle Ray-Coquard, et al.
Journal of Palliative Medicine
|
February 17, 2012
Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care
Sébastien Salas, Matthieu Frasca, Brigitte Planchet-Barraud, et al.
Targeted Oncology
|
June 5, 2021
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study
Almudena Callejo, Sara Faouzi, Olivier Bouché, et al.
Anti-Cancer Drugs
|
May 31, 2008
High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy
Charlotte Dupuis, Cedric Mercier, Chenguang Yang, et al.
Nature Communications
|
January 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial
Robin L Jones, Roman Groisberg, Jean-Yves Blay, et al.
Scientific Reports
|
June 5, 2017
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
François Becher, Joseph Ciccolini, Diane-Charlotte Imbs, et al.
Therapeutic Drug Monitoring
|
October 14, 2006
A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy
Joseph Ciccolini, Cédric Mercier, Alexandre Evrard, et al.
The Oncologist
|
August 22, 2012
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier, Anne Floquet, Nicolas Penel, et al.
Page
of 14